Part 2 • Diagnosis
Chapter 5 Diagnostic Testing
eye can be a window to the brain and provide insight into neurologic disease, evaluation of the brain and cerebrospinal fluid can give important clues to the underlying cause of
ocular inflammatory disease. For example, lumbar puncture is useful in evaluating patients with possible Vogt– Koyanagi–Harada syndrome or intraocular lymphoma.
References
1.Griner PF, Mayewski RJ, Mushlin AL, et al. Selection and interpretation of diagnostic tests and procedures: principles and applications, Ann Intern Med 1981; 94: 553–600.
2.Rembold CM, Watson D. Posttest probability calculation by weights: a simple form of Bayes’ theorem, Ann Intern Med 1988; 108: 115–120.
3.Rosenbaum JT, Wernick R. The utility of routine screening of patients
with uveitis for systemic lupus erythematosus or tuberculosis, Arch Ophthalmol 1990; 108: 1291–1293.
4.Warner HR, Toronto AF, Veasey LG, et al. A mathematical approach to medical diagnosis: application to congenital heart disease. JAMA 1961;
177:177–183.
5.Warner HR, Toronto AF, Veasy LG. Experience with Bayes’ theorem for computer diagnosis of congenital heart disease. Ann NY Acad Sci 1964; 115: 558–567.
6.Fagan TJ. Nomogram for Bayes’ theorem. N Engl J Med 1975; 293: 257.
7.Gorry GA, Barnett GO. Sequential diagnosis by computer. JAMA 1968;
205:849–854.
8.Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2007; 48: 3253– 3259.
9.Asukata Y, Ishihara M, Hasumi Y, et al. Guidelines for the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm 2008; 16: 77–81.
10.Leeflang MMG, Deeks JJ, Gatsonis C, et al, on behalf of the Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008;
149:889–897.
11.Passo MS, Rosenbaum JT. Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol 1988; 106: 1–6.
12.Tramont EC. Syphilis in the AIDS era. N Engl J Med 1987; 316: 1600–1601.
13.Quan T, Kan I, Craft JE. Diagnostic tests in rheumatic diseases. In: Goldman L, Ausiello D, eds. Cecil Textbook of Medicine. Philadelphia: WB Saunders, 2004;1627–1630.
14.Fauci AS, Haynes BF, Katz P, et al. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85.
15.Nolle B, Specks U, Ludemann J, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener’s granulomatosis. Ann Intern Med 1989;
111:28–40.
16.Cohen-Tervaert MD, van der Woude FJ, Fauci AS, et al. Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461–2465.
17.Young DW. The antineutrophil antibody in uveitis. Br J Ophthalmol 1991; 75: 208–211.
18.Soukasian SH, Foster CS, Niles JL, et al. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosis. Ophthalmology 1992;
99:125–132.
19.Nolle B, Coners H, Guncker G. ANCA in ocular inflammatory disorders. Adv Exp Med Biol 1993; 336: 305–307.
20.Power WJ, Rodriguez A, Neves RA, et al. Disease relapse in patients with ocular manifestations of Wegener
granulomatosis. Ophthalmology 1995;
102:154–160.
21.Bloch-Michel E, Timsit JC. Uveitis with allergy to candidin. Ophthalmologica 1985; 191: 102–106.
22.Desmonts G. Definitive serological diagnosis to ocular toxoplasmosis. Arch Ophthalmol 1966; 76: 839–
853.
23.Timsit JC, Fortier B, Pontet F, et al. Value of the immunoenzyme method (ELISA) in determining serum
and aqueous humor antiherpes immunoglobulin levels (apropos of 155 cases). J Fr Ophtalmol 1982; 5: 669–674.
24.Kaplan HJ, Lee FK, Waldrep JC, et al. Viral antibodies in the aqueous humor in idiopathic uveitis. In: Saari KM, ed. Uveitis update. Amsterdam: Excerpta Medica 1984; 437–442.
25.Kijlstra A, Breebaart AC, Baarsma GS, et al. Aqueous chamber taps in toxoplasmic chorioretinitis. Doc Ophthalmol 1986; 64: 53–58.
26.Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 2005; 140: 822–829.
27.Margolis R, Brasil OF, Lowder CY, et al. Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology 2007; 114: 1893–1897.
28.Weinreb RN, Tessler H. Laboratory diagnosis of ophthalmic sarcoidosis. Surv Ophthalmol 1984; 28: 653– 664.
29.Takata H. Electroretinographic studies of experimental uveitis. (III). Characteristics of B- and C-potential of ‘inflammation type ERG’. Nippon Ganka Kiyo 1963; 14: 409–415.
30.Ourgaud AG, Haudiquet G, Tassy AF. Clinical study and ERG (oscillatory potential) in Vogt–Koyanagi–Harada syndrome. Bull Soc Ophthalmol Fr 1966; 66: 470–475.
31.Feurst DJ, Tessler HH, Fishman GA, et al. Birdshot retinochoroidopathy.
Arch Ophthalmol 1984; 102: 214–219.
32.Gasch AT, Smith JA, Whitcup SM. Birdshot retinochoroidopathy. Br J Ophthalmol 1999; 83: 241–249.
33.Zacks DN, Samson CM, Lowenstein J, et al. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 2002; 240: 601–607.
34.Holder GE, Robson AG, Pavesio C, et al. Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol 2005; 89: 709–718.
35.Sobrin L, Lam BL, Liu M, et al. Electroretinographic monitoring in birdshot chorioretinopathy. Am J Ophthalmol 2005; 140: 52–64.
36.Kretschmann U, Schlote T, Stubiger N, et al. Multifocal electroretinography in acquired macular dysfunction. Klin Monatsbl Augenheilkd 1998; 212: 93–100.
37.Kretschmann U, Bock M, Gockeln R,
et al. Clinical applications of multifocal electroretinography. Doc Ophthalmol 2000; 100: 99–113.
38.Stubiger N, Besch D, Deuter CM, et al. Multifocal ERG changes in patients with ocular Behçet’s disease during therapy with interferon alpha 2a. Adv Exp Med Biol 2003; 528: 529–532.
39.Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Ophthalmology 1987;
94:1134–1139.
40.Fox IJ, Wood EH. Indocyanine green: physical and physiologic properties. Proc Mayo Clin 1960; 35: 732–744.
41.Kogure K, David NJ, Yamanouchi U, et al. Infrared absorption angiography of the fundus circulation. Arch Ophthalmol 1970; 83: 209–214.
42.Flower RW, Hocheimer BF. A clinical technique and apparatus for simultaneous angiography of the separate retinal and choroidal circulations. Invest Ophthalmol 1973;
12:248–261.
43.Flower RW, Hochheimer BF Indocyanine green dye fluorescence and infrared absorption choroidal angiography performed simultaneously with fluorescein angiography. Johns Hopkins Med J 1976; 138: 33–42.
44.Destro M, Puliafito CA. Indocyanine green videoangiography of choroidal neovascularizations. Ophthalmology 1989; 96: 846–853.
45.Bischoff P. Bedeutung der infrarotangiographie fur die differentialdiagnostik der aderhauttumoren. Klin Mbl Augenheilkd 1985; 186: 187–193.
70
46.Krupsky S, Friedman E, Foster CS, et al. Indocyanine green angiography in choroidal diseases. Invest Ophthalmol Vis Sci 1992; 33(suppl): 723.
47.Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt–Koyanagi–Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007; 27: 173–182.
48.Klaeger AJ, Tran VT, Hiroz CA, et al. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet’s uveitis. Int Ophthamol 2004; 25: 57–63.
49.Shah SM, Spalton DJ, Taylor JC. Correlations between laser flare measurements and anterior chamber protein concentrations. Invest Ophthalmol Vis Sci 1992; 33: 2878– 2884.
50.Guex-Crosier Y, Pittet N, Herbort CP. Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology 1994; 101: 728–735.
51.Ladas JG, Yu F, Loo R, et al. Relationship between aqueous humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci 2001; 42: 2584– 2588.
52.Gonzales CA, Ladas JG, Davis JL, et al. Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol 2001; 119: 1763–1769.
53.Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol 2003; 135: 763–771.
54.Antcliff RJ, Stanford MR, Chauhan DS, et al. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 2000; 107: 593–597.
55.Sivaprasad S, Ikeji F, Xing W, et al. Tomographic assessment of therapeutic
response to uveitis macular oedema. Clin Exp Ophthalmol 2007; 35: 719–723.
56.Gallagher MJ, Yilmaz T, CervantesCastaneda RA, et al. The characteristic features of optical coherence tomography in posterior uveitis.
Br J Ophthalmol 2007; 91: 1680– 1685.
57.Gupta V, Gupta P, Singh R, et al. Spectral-domain cirrus high-definition optical coherence tomography is better than time-domain stratus optical coherency tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol 2008;
(in press)
58.Tran VT, LeHoang P, Herbort CP. Value of high-frequency ultrasound biomicroscopy in uveitis. Eye 2001; 15: 23–30.
59.Doro D, Manfre A, Deligianni V, et al. Combined 50and 20-MHz frequency ultrasound imaging in intermediate uveitis. Am J Ophthalmol 2006; 141: 953–955.
60.Liebman PA, Leigh RA. Autofluorescence of visual receptors. Nature 1969; 221: 1249–1251.
61.von Ruckmann A, Schmidt KG, Fitzke FW, et al. Serous central chorioretinopathy. Acute autofluorescence of the pigment
epithelium of the eye. Ophthalmologe 1999; 96: 6–10.
62.Haen SP, Spaide RF. Fundus autofluorescence in multifocal choroiditis and panuveitis. Am J Ophthalmol 2008; 145: 847–853.
63.Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491.
64.Van Gelder RN. Applications of polymerase chain reaction to diagnosis of ophthalmic disease. Surv Ophthalmol 2001; 46: 248–258.
65.Forster DJ, Dugel PU, Frangieh GT, et al. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol 1990; 110: 341–348.
References
66.Chan CC, Palestine AG, Li Q, et al. Diagnosis of ocular toxoplasmosis by the use of immunocytology and the polymerase chain reaction. Am J Ophthalmol 1994; 117: 803–805.
67.Brezin AP, Egwuagu CE, Burnier M Jr, et al. Identification of Toxoplasma gondii in paraffin-embedded sections by the polymerase chain reaction. Am J Ophthalmol 1990; 110: 599–604.
68.Update: nucleic acid amplification tests for tuberculosis, MMWR Morbid Mortal Wkly Rep 2000; 49: 593–
594.
69.Therese KL, Jayanthi U, Madhavan HN. Application of nested polymerase chain reaction (nPCR) using MPB 64 gene primers to detect Mycobacterium tuberculosis DNA in clinical specimens from extrapulmonary tuberculosis patients. Indian J Med Res 2005; 122: 165–170.
70.Matos K, Muccioli C, Belfort R Jr, et al. Correlation between clinical diagnosis and PCR analysis of serum, aqueous, and aqueous and vitreous samples in patients with inflammatory eye disease. Arq Bras Oftalmol 2007: 70: 109–114.
71.Rickman LS, Freeman WR, Green WR. Brief report: uveitis caused by
Tropheryma whippelii (Whipple’s bacillus), N Engl J Med 1995; 332: 363–366.
72.Lukert BP, Raisz LG. Glucocorticoidinduced osteoporosis. Rheum Dis Clin North Am 1994; 20: 629–650.
73.Jones NP, Anderton LC, Cheong FM, et al. Corticosteroid-induced osteoporosis in patients with uveitis. Eye 2002; 16: 587–593.
74.Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275: 668–670.
75.Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular mesh-work inducible glucocorticoid response gene product. Ophthalmologica 1997; 211: 126–139.
71